Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Vistagen Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −19 vs. Q2 2022
- Shares held
- 56.5M
- −82.3M (−59.3%) vs. Q2 2022
- Total value
- $9.13M
- −$113.0M (−92.5%) vs. Q2 2022
- New holders
- 17
- 33 more added
- Sold out
- 36
- 27 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Epiq Partners, LLC | 0 | $0 | 0.00% | −1,301,350−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −825,000−100.0% | Sold out |
| Oak Family Advisors, LLC | 0 | $0 | 0.00% | −390,742−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −381,500−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −360,475−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −331,587−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −175,100−100.0% | Sold out |
| Dorsey & Whitney Trust CO LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −133,291−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −138,385−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −88,939−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −75,121−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −68,811−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −36,474−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −36,157−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −29,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −23,461−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −23,097−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,857−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −19,080−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −16,911−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −15,192−100.0% | Sold out |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −14,723−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −13,274−100.0% | Sold out |
| Integrated Advisors Network LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,950−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −1,238−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −600−100.0% | Sold out |